Editorial [ Hot Topic: Wnt Signaling (Guest Editor: Rashna D. Balsara) ]
Journal:
Current Drug Targets
Volume:
9
Page:
511-512
Author(s):
Rashna D. Balsara
Wnt Signaling in Development, Disease and Translational Medicine
Journal:
Current Drug Targets
Volume:
9
Page:
513-531
Author(s):
Gary S. Coombs, Tracy M. Covey and David M. Virshup
Targeting the Most Upstream Site of Wnt Signaling Pathway Provides a Strategic Advantage for Therapy in Colorectal Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
548-557
Author(s):
Jian Qi and You-Qing Zhu
Wnt Signaling and Prostate Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
271-580
Author(s):
Daniel R. Robinson, Cassandra R. Zylstra and Bart O. Williams
Wnt Signaling in Renal Cancer
Journal:
Current Drug Targets
Volume:
9
Page:
591-600
Author(s):
Hector Guillen-Ahlers
Current Adjuvant and Targeted Therapies for Pancreatic Adenocarcinoma
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
1674-1683
Author(s):
Sabrina E. Sanchez and Jose G. Trevino
Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Journal:
Current Drug Metabolism
Volume:
9
Page:
520-531
Author(s):
Jose A.G Agundez
Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2051-2060
Author(s):
M. P. Bernard, S. Bancos, P. J. Sime and R. P. Phipps
A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2085-2099
Author(s):
Silvia Sancilio, Vittorio Grill and Roberta Di Pietro
Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents
Journal:
Current Topics in Medicinal Chemistry
Volume:
8
Page:
841-858
Author(s):
Oscar Moradei, Arkadii Vaisburg and Robert E. Martell